Inhibition of PI3K and MEK: It Is All about Combinations and Biomarkers

MLA

Carlos L. Arteaga, et al. “Inhibition of PI3K and MEK: It Is All about Combinations and Biomarkers.” Clinical Cancer Research, vol. 15, July 2009, pp. 4518–20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....71dd9dc6db151e4ac90670059049752b&authtype=sso&custid=ns315887.

APA

Carlos L. Arteaga, Brent N. Rexer, & Ritwik Ghosh. (2009). Inhibition of PI3K and MEK: It Is All about Combinations and Biomarkers. Clinical Cancer Research, 15, 4518–4520.

Chicago

Carlos L. Arteaga, Brent N. Rexer, and Ritwik Ghosh. 2009. “Inhibition of PI3K and MEK: It Is All about Combinations and Biomarkers.” Clinical Cancer Research 15 (July): 4518–20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....71dd9dc6db151e4ac90670059049752b&authtype=sso&custid=ns315887.